Anti-inflammatory potential of β-cryptoxanthin against LPS-induced inflammation in mouse Sertoli cells. 2016

Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
Key Laboratory of China Education Ministry in Agricultural Animal Genetics, Breeding and Reproduction, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan, P.R. China, 430070.

β-cryptoxanthin (CX), a major carotenoid pigment, can inhibit inflammatory gene expression in mice with nonalcoholic steatohepatitis. In the present study, we examined the anti-inflammatory effects of CX on lipopolysaccharide (LPS)-induced inflammation in mouse primary Sertoli cells and the possible molecular mechanisms behind its effects. The results showed that CX significantly inhibited LPS-induced decreases in cell viability and in the percentage of apoptotic cells. Moreover, CX inhibited the LPS-induced up-regulation of tumor necrosis factor α (TNF-α), interleukin-10 (IL-10), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in Sertoli cells. In addition, CX significantly limited the LPS-induced down-regulation of AR, HSF2, CREB, FSHR, INHBB and ABP in Sertoli cells. Western blot analysis showed that CX significantly suppressed NF-κB (p65) activation as well as MAPK phosphorylation. All the results suggested that CX suppressed inflammation, possibly associated with the NF-κB activation and MAPK of phosphorylation. Thus, CX may possess therapeutic potential against inflammation-related diseases.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D000072743 Beta-Cryptoxanthin A mono-hydroxylated xanthophyll that is a provitamin A precursor. Beta Cryptoxanthin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012708 Sertoli Cells Supporting cells projecting inward from the basement membrane of SEMINIFEROUS TUBULES. They surround and nourish the developing male germ cells and secrete the ANDROGEN-BINDING PROTEIN and hormones such as ANTI-MULLERIAN HORMONE. The tight junctions of Sertoli cells with the SPERMATOGONIA and SPERMATOCYTES provide a BLOOD-TESTIS BARRIER. Sertoli Cell,Cell, Sertoli,Cells, Sertoli
D013091 Spermatogenesis The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA. Spermatocytogenesis,Spermiogenesis

Related Publications

Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
February 2023, Inflammopharmacology,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
January 2023, Journal of inflammation (London, England),
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
September 2021, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
March 2023, Molecules (Basel, Switzerland),
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
October 2022, Biomedicines,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
January 2019, Journal of agricultural and food chemistry,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
June 2024, Biomolecules & therapeutics,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
February 2020, Archives of physiology and biochemistry,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
January 2020, Frontiers in immunology,
Xiao-Ran Liu, and Yue-Ying Wang, and Xin-Gang Dan, and Ashok Kumar, and Ting-Zhu Ye, and Yao-Yao Yu, and Li-Guo Yang
August 2021, Medicines (Basel, Switzerland),
Copied contents to your clipboard!